Paper · 35196078
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer.
Zhang K and 16 others. Sci Adv, 2022. Cited by 154 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer. Papers, record 35196078. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35196078
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance, Neoplasm | Major topic |
| Ovarian Neoplasms | Major topic |
| Female | |
| Humans | |
| Sequence Analysis, RNA | |
| Transcriptome | |
| Exome Sequencing |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,239,542 | Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy. | Br J Cancer | 2019 | https://conductscience.org/library/papers/31239542 | PubMed |
| 2 | 28,899,397 | Splatter: simulation of single-cell RNA sequencing data. | Genome Biol | 2017 | https://conductscience.org/library/papers/28899397 | PubMed |
| 3 | 31,819,264 | NicheNet: modeling intercellular communication by linking ligands to target genes. | Nat Methods | 2020 | https://conductscience.org/library/papers/31819264 | PubMed |
| 4 | 28,232,471 | Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. | J Exp Med | 2017 | https://conductscience.org/library/papers/28232471 | PubMed |
| 5 | 31,948,481 | A benchmark of batch-effect correction methods for single-cell RNA sequencing data. | Genome Biol | 2020 | https://conductscience.org/library/papers/31948481 | PubMed |
| 6 | 28,960,196 | Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations. | Nat Methods | 2017 | https://conductscience.org/library/papers/28960196 | PubMed |
| 7 | 23,945,592 | Signatures of mutational processes in human cancer. | Nature | 2013 | https://conductscience.org/library/papers/23945592 | PubMed |
| 8 | 31,484,791 | Overcoming adaptive therapy resistance in AML by targeting immune response pathways. | Sci Transl Med | 2019 | https://conductscience.org/library/papers/31484791 | PubMed |
| 9 | 28,611,107 | IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma. | Mol Cancer Ther | 2017 | https://conductscience.org/library/papers/28611107 | PubMed |
| 10 | 30,366,930 | IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. | Cancer Discov | 2019 | https://conductscience.org/library/papers/30366930 | PubMed |
1 to 10 of 72
See all 72 referencesCited by130
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 154 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,982,893 | Stromal APOL4 defines a cancer-associated fibroblast state that organizes a chemosensitive niche in ovarian cancer. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/42982893 | PubMed |
| 42,974,638 | Artificial intelligence assisted genomic profiling of ovarian cancer liver metastases. | Front Genet | 2026 | https://conductscience.org/library/papers/42974638 | PubMed |
| 42,962,034 | Evidence of active whole-genome doubling (WGD) subclones in non-WGD tumors. | Sci Adv | 2026 | https://conductscience.org/library/papers/42962034 | PubMed |
| 42,923,094 | Epigenetic adaptations and vulnerabilities in ovarian cancer drug-tolerant persister cells. | NAR Cancer | 2026 | https://conductscience.org/library/papers/42923094 | PubMed |
| 42,911,976 | Multi-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns based upon clinico-genomic status. | PLoS Genet | 2026 | https://conductscience.org/library/papers/42911976 | PubMed |
| 42,811,363 | Uncovering pan-cancer signatures of chemoresistance. | Genome Med | 2026 | https://conductscience.org/library/papers/42811363 | PubMed |
| 42,633,216 | Chronic stress and myeloid immunosuppression in cancer: A neuroimmune link to behavioral dysfunction. | Brain Behav Immun Health | 2026 | https://conductscience.org/library/papers/42633216 | PubMed |
| 42,621,564 | Diversity within ovarian cancer subtypes and their tumor microenvironment. | Front Oncol | 2026 | https://conductscience.org/library/papers/42621564 | PubMed |
| 42,605,287 | Single-Cell Transcriptome Analysis Reveals IRF1-Driven Epithelial States and Glycosaminoglycan-Glycolysis Coupling in Cisplatin-Resistant HGSOC. | Cancer Inform | 2026 | https://conductscience.org/library/papers/42605287 | PubMed |
| 42,564,493 | DUSP5 contributes to platinum resistance in ovarian cancer: single-cell discovery and functional validation. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42564493 | PubMed |
1 to 10 of 130
See all 130 cited byGenes97
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACTA2 | 59 | PubTator's text mining | https://conductscience.org/library/genes/59 | NCBI Gene |
| AKR1C4 | 1,109 | PubTator's text mining | https://conductscience.org/library/genes/1109 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| ATF3 | 467 | PubTator's text mining | https://conductscience.org/library/genes/467 | NCBI Gene |
| BCL6 | 604 | PubTator's text mining | https://conductscience.org/library/genes/604 | NCBI Gene |
| BIRC3 | 330 | PubTator's text mining | https://conductscience.org/library/genes/330 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| C1QA | 712 | PubTator's text mining | https://conductscience.org/library/genes/712 | NCBI Gene |
1 to 10 of 97
See all 97 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35196078
GET https://conductscience.org/api/papers/v1/35196078/references?page=2